article thumbnail

ORBITA 2: The power of PCI revealed for stable angina

Cardiology Update

The ORBITA-2 trial ( NCT03742050 ) investigated the efficacy of Percutaneous Coronary Intervention (PCI) compared to placebo in 301 patients with stable angina. At the 12-week mark, the PCI group exhibited a significantly lower mean angina score (2.9) compared to the placebo group (5.6; odds ratio, 2.21; 95% CI, 1.41-3.47;

Angina 52
article thumbnail

A budget impact model and a cost–utility analysis of reducer device (Neovasc) in patients with refractory angina

Frontiers in Cardiovascular Medicine

Background Refractory angina (RA) is a chronic condition characterized by the presence of debilitating angina symptoms due to established reversible ischemia in the presence of obstructive coronary artery disease (CAD).

Angina 64
article thumbnail

Decoding the Menace Within: Unraveling Myocardial Bridges and Exercise-Induced Ischemia

Cardiology Update

The perplexing landscape of angina with nonobstructive coronary arteries (ANOCA) encompasses diverse pathophysiological entities, including coronary microvascular disease (CMD), coronary artery spasm, and the enigmatic myocardial bridging (MB). Original article: Sinha A et al.

Exercise 119
article thumbnail

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

DAIC

Results from the open label roll-in cohort of patients having chronic myocardial ischemia with refractory angina showed an average increase in exercise tolerance of 107 seconds and an average of 82% reduction in angina episodes at the primary six-month follow-up endpoint compared to before receiving the study treatment.

article thumbnail

Revascularization Strategies in Stable Coronary Artery Disease: ISCHEMIA Trial Insights

Cardiology Update

In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronary artery disease. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram.

article thumbnail

Researchers urge caution in co-prescribing potency drugs and nitrates

Medical Xpress - Cardiology

Co-prescribing potency drugs such as Viagra and organic nitrates for angina is associated with a 35% to 40% increased risk of death and about 70% higher risk of heart attack and heart failure. The Swedish researchers are now urging caution.

article thumbnail

POST-PCI Surveillance Strategies for Multivessel or Left Main Coronary Artery Disease

Cardiology Update

The primary outcome was a composite of death from any cause, myocardial infarction, or hospitalization for unstable angina at 2 years. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. The analysis composed of participants with multivessel or left main CAD.